Epinastine Hydrochloride (Offer to Sell)
Trade Lead Description:
A histamine H1 receptor antagonist. Epinastine Hydrochloride, a second generation antihistamine API, is clinically used for allergic rhinitis, urticaria, eczema, dermatisis, pruritis of skin, psoriasis, and allergic bronchial asthma et al. Epinastine Hydrochloride reveals a wide indication spectrum, a fast effect and a long action time. Epinastine Hydrochloride produced in CREDIT CHEMWERTH, with an assay content of NLT 99.5% and total impurity content of NMT 0.2%, is anticipating for FDA’s inspection for cGMP compliance, and CREDIT CHEMWERTH already had whose DMF filed. This product is for international market except those in north America. Posted from China - Sichuan on 24 July, 2008
|
|